Delve into the field of RAS inhibitors, an area of biotechnology that is increasingly diversifying to tackle pancreatic cancer, among other cancers. The post RAS inhibition enters its second wave appeared first on Labiotech.eu . © Labiotech UG and Labiotech.eu. Unauthorized use and/or duplication of this material without express and written permission from this site’s author and/or owner is strictly prohibited. Excerpts and links may be used, provided that full and clear credit is given to Labiotech UG and Labiotech.eu with appropriate and specific direction to the original content.